CIMINO, Sebastiano
 Distribuzione geografica
Continente #
NA - Nord America 475
EU - Europa 383
AS - Asia 108
AF - Africa 2
SA - Sud America 2
Totale 970
Nazione #
US - Stati Uniti d'America 474
IE - Irlanda 147
SE - Svezia 116
CN - Cina 96
IT - Italia 54
DE - Germania 20
FI - Finlandia 18
UA - Ucraina 14
SG - Singapore 10
FR - Francia 4
GB - Regno Unito 3
NL - Olanda 3
BE - Belgio 2
DZ - Algeria 2
IN - India 2
PE - Perù 2
CA - Canada 1
CZ - Repubblica Ceca 1
ES - Italia 1
Totale 970
Città #
Chandler 147
Dublin 147
Beijing 45
Jacksonville 44
Nyköping 33
Ashburn 26
Princeton 21
Dearborn 20
Cambridge 18
Des Moines 17
Medford 14
Messina 10
Boardman 9
San Mateo 9
Jinan 6
Rome 6
Singapore 6
Taizhou 6
Milan 5
Naples 5
Wilmington 5
Changsha 4
Sciacca 4
Haikou 3
Hangzhou 3
Hebei 3
Nanchang 3
Nanjing 3
Ningbo 3
Seattle 3
Shenyang 3
Tianjin 3
Brussels 2
Fuzhou 2
Houston 2
Lanzhou 2
Lima 2
Los Angeles 2
New York 2
Norwalk 2
Pune 2
Santa Monica 2
Zhengzhou 2
Augusta 1
Boston 1
Bremen 1
Brno 1
Buffalo 1
Clearwater 1
Guangzhou 1
Iseo 1
Las Vegas 1
Monmouth Junction 1
Nanning 1
Niscemi 1
Orciano Di Pesaro 1
Ottawa 1
Palermo 1
Phoenix 1
Taiyuan 1
Torino 1
Washington 1
Woodbridge 1
Totale 676
Nome #
Echocardiographic reference ranges for normal non-invasive myocardial work indices: results from the eacvi norre study 62
EVALUATION OF EXTRA CELLULAR SIGNAL-REGULATED KINASES 1/2 (ERK 1/2), EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AND P53 PROTEIN AS BIOMARKERS OF CANCER PROGRESSION IN BLADDER CANCER TUMOURS 61
PHI and PCA3 improve the prognostic performance of PRIAS and Epstein criteria in predicting insignificant prostate cancer in men eligible for active surveillance 58
Nutraceutici attivi in Urologia” Nutraceutici ed alimenti funzionali in medicina preventiva 57
RUOLO DEL DNA COMET ASSAY NELLA STADIAZIONE DEL CANCRO DELLA PROSTATA 56
Effects of Serenoa repens, selenium and lycopene (Profluss®) on chronic inflammation associated with benign prostatic hyperplasia: results of "FLOG" (Flogosis and Profluss in Prostatic and Genital Disease), a multicentre Italian study. 55
Dietary patterns and prostatic diseases. 54
Non­invasive myocardial work indices in patients undergoing mitraclip implantation 51
Survivin and NAIP in Human Benign Prostatic Hyperplasia: Protective Role of the Association of Serenoa repens, Lycopene and Selenium from the Randomized Clinical Study 49
Validation of the 2009 TNM version in a large multi-institutional cohort of patients treated for renal cell carcinoma: Are further improvements needed? 48
New advances in clinical biomarkers in testis cancer 47
Effects of Serenoa Repens Lycopene e Selenium, on pro-inflammatory phenotype activation: an “in vitro” and “in vivo” comparison study 47
Use of alfa 1 blockers in female functional bladder neck obstruction 45
Molecular markers for prostatic cancer 42
Relationship between lower urinary tract symptoms and serum levels of sex hormones in men with symptomatic benign prostatic hyperplasia. 41
Nerve grafting radical prostatectomy: 24 months results in a single institution 40
1472 evaluation of extra cellular signal-reguladed kinases ½ (ERK1/2), epidermal growth factor receptor (EGFR) and P53 protein as biomarkers of cancer progression in bladder cancer 39
Conversion to sirolimus therapy in kidney transplant recipients with new onset diabetes mellitus after transplantation. 36
Endothelial progenitor cells and erectile dysfunction: a brief review on diagnostic significance and summary of our experience. 35
Expression of CD7, CD20 and CDX-2 in a secondary signet-ring cell tumor of the prostate: a case report. 34
Vascular regenerative therapies for the treatment of erectile dysfunction: current approaches. 31
Totale 988
Categoria #
all - tutte 3.875
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.875


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020103 7 1 1 0 0 19 14 3 1 37 20 0
2020/2021111 11 0 20 10 7 11 9 11 3 9 12 8
2021/2022164 0 37 0 10 1 1 3 6 0 50 17 39
2022/2023418 25 46 11 43 24 51 0 19 188 1 10 0
2023/202498 9 13 8 25 5 12 0 1 7 4 3 11
2024/20252 2 0 0 0 0 0 0 0 0 0 0 0
Totale 988